Grifols · 2 months ago
Marketing Analytics Intern
Grifols is a global healthcare company that has been working to improve the health and well-being of people around the world since 1909. The Marketing Analytics Intern will support the procurement marketing team in donor acquisition and retention efforts by performing data analysis and collaborating with subject matter experts to enhance business processes.
BiotechnologyHealth CareManufacturing
Responsibilities
Perform data collection, collation, quality control, and analysis against large and varying data sets related to Grifols donors, marketing campaigns, and competitors
Translate current business challenges into analytical terms and use appropriate data analysis techniques to support key business strategies and uncover areas for potential
Communicate data discoveries and analysis in impactful presentations
Work cross-functionally to collaborate with area subject matter experts to improve business processes
Qualification
Required
Candidate must be currently enrolled in 4-year degree program pursuing Bachelor's degree in Business/Marketing, Data/Analytics, or Computer Science as rising junior or senior OR currently accepted or enrolled in Master's or PhD program
Candidate must currently have GPA of 3.0 or higher
Familiarity/comfort with Excel, including working with Macros and pivot tables; Microsoft word and PowerPoint
Preferred
Experience with SQL or Salesforce systems is a plus
Company
Grifols
Grifols is a global healthcare company.
H1B Sponsorship
Grifols has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2023 (2)
2022 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.51BKey Investors
Michael J. Fox Foundation
2025-01-14Grant· $21M
2024-06-04Post Ipo Debt· $1.41B
2024-04-23Post Ipo Debt· $1.07B
Leadership Team
Recent News
2025-12-24
Pharma Letter
2025-11-28
Company data provided by crunchbase